Olin: Chemistry and Cash Flows - [Business Breakdowns, EP.132]

18 Oct 2023 · 58 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Episode Summary: Olin: Chemistry and Cash Flows - [Business Breakdowns, EP.132]

Overview

  • Podcast Title: Business Breakdowns
  • Episode Title: Olin: Chemistry and Cash Flows
  • Hosts: Matt Reustle and Zack Fuss
  • Guest: Yinan Zhao (Pzena Investment Management)
  • Release Date: [Episode Page Link](http://www.joincolossus.com)

This episode explores Olin Corporation, a significant player in the industrial chemicals space, particularly known for its production of chlor-alkali products and ammunition through its Winchester brand. The discussion delves into Olin's business model, operational adjustments for profit sustainability, and its place in the broader chemical market.

---

Key Takeaways

Company Background

  • Founding and Evolution:
  • Founded in 1892 as the Equitable Powder Company, Olin began as a supplier of blasting powder.
  • Acquired Winchester in 1931, expanding into ammunition.
  • Merged with Matheson Chemical in 1954, establishing a strong foothold in the chlor-alkali business.

Chlor-alkali Market Explained

  • Process Overview:
  • Chlor-alkali production involves electrolysis of salt (NaCl) and water (H2O) to produce chlorine (Cl) and caustic soda (NaOH).
  • Both products have diverse industrial applications, with chlorine primarily used in housing construction (PVC) and caustic soda in various manufacturing processes.

Business Operations

  • Manufacturing Dynamics:
  • Olin operates numerous plants, strategically located near salt deposits and cost-effective electricity sources.
  • The company’s production strategy shifted post-Dow acquisition, emphasizing flexibility and optimization to manage supply in fluctuating markets.

Financial Insights

  • Revenue Breakdown:
  • Chlor-alkali business typically yields over 80% of total EBITDA at peak times, though this can drop significantly during downturns.
  • In contrast, the Winchester business remains stable and cash-generative, providing a cushion during cyclic downturns.

Strategic Shifts

  • Leadership Change:
  • Scott Sutton, who became CEO in 2020, implemented a value-over-volume strategy, pivoting focus to optimize pricing rather than just increase production.
  • Sutton's approach has led to significant EBITDA growth, even amidst broader economic challenges.

Risks and Concerns

  • CEO Departure:
  • Sutton’s announced departure raised concerns regarding continued execution of the new strategy and its impact on stock performance.
  • Market Volatility:
  • The chlor-alkali business remains subject to cyclical swings, and potential oversupply could create pressures on pricing.

ESG Considerations

  • Environmental Impact:
  • The chlor-alkali industry faces scrutiny over carbon emissions and energy consumption, necessitating innovations for sustainability.
  • Winchester Business Impact:
  • The ammunition segment poses challenges for ESG-conscious investors, impacting Olin's overall market perception.

Lessons Learned

  • Investment Philosophy:
  • The Olin case highlights the need for questioning conventional wisdom and adapting investment theses to evolving company strategies.
  • There exist valuable opportunities in cyclical commodity industries if the company maintains a strong cost position and balance sheet.

---

Conclusion The episode presents a comprehensive breakdown of Olin Corporation, highlighting its historical evolution, market dynamics, strategic pivots under new leadership, and the financial implications of its operational strategies. The discussion offers important insights for investors and industry stakeholders looking to understand the complexities of the chemical market and the broader implications of corporate strategies on performance and sustainability.

For further exploration, listeners are encouraged to engage with the full episode and other interesting breakdowns available on the Business Breakdowns podcast.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:03This is Business Breakdowns. Business Breakdowns is a series of conversations with investors and operators diving deep into a single business. For each business, we explore its history, its business model, its competitive advantages, and what makes it tick. We believe every business has lessons and secrets that investors and operators can learn from, and we are here to bring them to you. To find more episodes of Breakdowns, check out joincollossus .com. All opinions expressed by hosts and podcast guests are sole their own opinions. Hosts, podcast guests, their employers, or affiliates, may maintain positions in the securities discussed in this podcast.

0:45This podcast is for informational purposes only and should not be relied upon as a basis for investment decisions. This is Matt Russell and today we are breaking down Olincorp. If you ever wondered when that high school chemistry class would come in handy, now is the time. Olin is a key player in industrial chemicals, but many of those chemicals are used in products that we interact with or see on a day -to -day basis. To break down Olin, I'm joined by Yinen Zau from Zina Investment Management. Together we cover the Chlor Alkalai market. What it means to be the lowest cost producer of a given commodity.

1:24And how Olin has shifted its business model and shifted its operational model to help sustain earnings through cycles. Please enjoy this breakdown of OlinCorp. All right, Enon, thank you for joining us on business breakdowns today. Olin is not a household name by any means. and I will admit to having absolutely no familiarity with this business prior to doing some research. So I think the best place to start is with a lot of background on the business, just a level set before we get into operational and financial dynamics. So maybe we could start with the very high level view, the 30 -second elevator pitch for who Olin is and what they do.

2:04Sure. So I think like you, most of your listeners probably have never heard of Olin, The only consumer -facing product that Olin does have in its portfolio that some of your listeners may be familiar with is Winchester, and that's the brand under which Olin manufactures and sells ammunition. But outside of Winchester, Olin's portfolio primarily consists of non -consumer -facing industrial chemicals, and so it's certainly not a household name. I think what's underappreciated about Olin is that the industrial products that it does manufacturer are really critical in the production of many goods and services that we use on a daily basis.

2:45And that list of applications, ranges from everything including plumbing and siding and windows and doors that are found in homes to the foam that's in mattress or furniture to the aluminum in your car, the soap and detergents. It's also used to help keep the water that we drink clean and safe. I think something like 90 % of the tap water consumed in the US is treated with oil and products. So it's definitely not one of those companies that most people have never heard of, but that has a pretty meaningful impact on our lives every day. It reminds me of business breakdown that we did on DuPont in that way.

3:27Is it right to think about the investors that are looking at DuPont are likely the ones looking at oil and from a subsector perspective. So there may be some overlap, but as you probably learned on the DuPont podcast, Dow and DuPont merged, I think it was back in 2015 and 2016, and then the idea of that merger was to separate those three businesses into three more focused businesses with Dow owning the commodity upstream part of the assets, DuPont owning the downstream specialty assets, and then Corteva owning the crop science and ag chemicals businesses. is I would put Olin more in the commodity part of that value chain.

4:08And so it's more like a commodity chemical company like the Dow than it is like a dupent. Yeah, I probably should have been specific about which part of that business because it looks a lot different today than it did when we did that breakdown. Maybe we can go back in time here. I know there is a rich history in terms of how everything came together. So maybe you can walk us through that history of the business. Sure. Absolutely. So, Olin has a really long history. In fact, the founding of the company dates back to the late 19th century. Franklin Olin founded, at the time it was called the Equitable Powder Company in 1892.

4:44An equitable really started as a blasting powder supplier in Illinois. The primary customers were mining and construction companies. And over time, he expanded into various adjacencies, including ammunition manufacturing. I mean, he did that through the Western cartridge company, the Western cartridge company in 1931 acquired Winchester, which was a firearm manufacturer, out of bankruptcy. Around the same time that equitable powder was founded, Mathis and Chemical was founded in Virginia. And Mathis and Bill, the first chloralculi plant in the US in South Bill, Virginia. And then they went on to build more chloralkyly plants in various locations across the country, including Niagara Falls and upstate New York, Lake Charles, Louisiana, Macintosh, Alabama.

5:33And a lot of those early chloralkyly plants were built either near salt deposits or near cheap sources of electricity. And this is because as we'll get into later, salt and electricity are the primary feedstocks for the chloralkyly industry. And so Niagara Falls was chosen because of access to cheap hydro, salt, villa, macintosh, and we're both near -salt deposits. And if you fast forward another 50 years from the founding of equitable powder of Matheson to 1954, that was the year when Olin, which is the the Blastin powder ammunition inside of the company, merged with Matheson Chemical, the Chloralchlide business.

6:14And that really laid the foundation for what we know is Olin today. After that merger, the combined company continued to enter into adjacent chemical and industrial businesses, but over the years they spun off or sold most of those businesses to pair back down to the Cloralcola business, plus a smaller, less core, but still very cash -generative Winchester ammunition business. And if you fast forward another 50 years to 2015, well, a particularly important transaction occurred that year as well. And that was when and Olin acquired Dow Chemicals, Chloralkylion, Chlorine, Derivatives, businesses.

6:53And Dow had initially only wanted to sell part of the business, specifically to downstream Chlorine Derivatives businesses. The Olin said they were interested, but only if Dow were to include a larger portion of the portfolio, including the upstream Chloralkylion assets, And ultimately the deal that got done saw Olin getting the majority of Dow's chloralculi assets. And that transaction really was transformative for Olin because it made Olin the leading chloralculi producer in North America. And I think just as importantly, it added significantly to the number of different chlorine derivatives that Olin was able to produce.

7:36And that will become an important point as we dig into the change in operating philosophy at Olin. Yeah, it's always interesting with these businesses that have 100 plus years of history where they typically have these errors of becoming diversified conglomerates. And there's usually some relation to the product offering, but then over time they start to actually divest a lot of those assets and become more focused. It certainly sounds like the case here where even the future transactions kept them focused in the Chloralcholide business. I do think I'll need 101 on chloralkylis. So as much of a rundown as you can give in terms of what's happening within that market, the inputs and the outputs of how chloralkylis used, it's something I know of, but I don't know well.

8:23So whatever primer you can give us is going to be helpful here. Sure, absolutely. I think at a high level, it refers to the production of chlorine and caustic soda. And that's done through a chemical reaction involving salt, water, and electricity. So pretty simple when you put it that way, but much more complicated in practice. The two molecules that are produced, chlorine and caustic soda, are in fact coproduced. And they're coproduced from the same electrolysis process. Generally speaking, in all electrolysis processes, what you're doing is you're running an an electric current to drive a chemical change that wouldn't naturally occur under normal conditions.

9:10And in this particular electrolysis setup, you're running an electrical current through a mixture of NaCl, aka salt, and water, H2O. And out of that chemical reaction, you get a reformulation of the NaCl and the H2O into three things. So, CL, which is chlorine, NAOH, which is more commonly known as caustic soda, sodium hydroxide, as well as a small residual amount of hydrogen. But people don't really talk about hydrogen that much because in most setups, the hydrogen is just released into the atmosphere. Now, generally speaking, because chlorine is difficult to transport and store due to its toxicity, the chloralculide production is set up to produce chlorine with caustic soda treated as a byproduct.

10:06And so it's imperative to have outlets for the chlorine that you produce since that can be a limiting production factor. In terms of the various outlets for chlorine, you can further process that chlorine into a range of derivatives, or you can sell it merchant, and the various chlorine derivatives all have various use cases. But the largest end market, by far, is residential housing construction, where you'll find it in the form of PVC. And that's Polyvinyl Chloride, which is a type of rigid plastic that can be used to make, as I said earlier, vinyl siding, doors, windows, and pipes for plumbing.

10:49The other molecule that's produced is caustic soda. And caustic soda is generally not processed any further by the chloralkylic producer. It's just sold as is, but it does have a wide range of industrial uses as well, including as a processing aid for the production of alumina, various other metals, pulp and paper, just to name a few industries. It can also be used as of raw material in general manufacturing for things like soap and super absorbent polymers, like diapers, feminine hygiene products, etc. As a result of the different end market applications for the two molecules, what's interesting about the chloralkylide business is that one side of the molecule, chlorine, demand tends to be driven by housing construction and the other side, the other molecule that's co -produced, caustic soda is driven by general industrial activity and And the two can move together, but often move at different rates.

11:51I'm going to oversimplify here, but it sounds like there's similarities to a crude oil refining process where the oil is taken, the hydrocarbons are then refined through some process involving a lot of energy to create various types of fuels and some byproducts, which may or may not be used jet fuel and just traditional gasoline. is it safe to make that comparison just in terms of, from a very high level, the overall process of what's going on? So I think that's a fair analogy for the chlorine side of the chloralkylic production process. Since the chlorine is often processed further into various chlorine derivatives, and you have some flexibility in terms of which derivatives chain to direct the chlorine molecules to in order to maximize value.

12:40but the degree of flexibility really varies from producer to producer depending on their setup. And I'm going to ask the question that I assume a lot of listeners will be wondering themselves, which is, is this chlorine ever used within a residential pool or for any pool purpose? Or is that a completely separate chlorine? It is. That's right. This is the type of chlorine that would be used in a pool. I'm not sure that you would be buying it directly from a brand name that Poland produces, but they'll be selling it to someone who produces chlorine that might end up in your fool. I think we can talk a little bit about how that operation actually works and specifically for Poland.

13:21How do they access the chloralkali? How is it transported in terms of making its way through that process and then distributed to whoever the buyer is who I assume is the manufacturer of that broader manufacturing process? Can you just go through a little bit of what that looks like in terms of the operations and which part Olin is controlling versus what's outsourced and how the dollars are changing hands in this particular value change? As I mentioned the two key feedstocks are salt and electricity When Matheson in 1890 I think was 97 built the first plant in saltwood, Virginia They built it in salt bill because there was a salt dome in salt goes as cheap access to salt I think the same with Macintosh.

14:08In Niagara Falls, I believe they have access to salt, that's maybe 50 miles away. So you want to be close to a source of salt, and ideally you want to have a stable, steady, and cheap source of electricity. Post the Dow acquisition, Olin in addition to the legacy, Mathis in sites in Niagara Falls, in Macintosh, And they also have a site in Charleston, Tennessee. They acquired two large plants in the US Gulf Coast, in Placameen and in Freeport. The interesting thing about the US Gulf Coast is that it's actually the most cost advantage region in the world due to cheap self -encheeb electricity. And the reason for that is that really goes back to the Shell Revolution in the early 2010s Because of a revolution in the way we're able to access shell formations and drill oil and gas, natural gas became really abundant in the US.

15:14And most of the electricity that we consume in the US is generated from natural gas. And so, all in at some of their sites, they have cogen facilities that they own and operate producing electricity for their plants. In some sites, they have access to the co -gen plants site partner that provides a source electricity. And in other regions, they are able to buy electricity from the grid. The grid is strong enough to support the quantity and volume of electricity that they need. And then with salt, the US Gulf Coast, and particularly in Texas and Louisiana area, there are lots of underground salt formations that Poland has access to with very abundant sources of that salt.

16:04Beyond Poland's portfolio, there are a lot of other companies in the US that are also concentrated in that region like West Lake, like OxyCam for most Asian tech. and then in terms of what they produce, as I said, there's a wide range of products that they can produce, and depending on what it is, the distribution and the end customer is different. I think what's unique about Olin versus their peers is that unlike their peers, Olin is not as forward -integrated into the vinyl chain, which is the PDC chain. In fact, before the Dow merger, Olin was somewhat of a one trick pony and it only sold chlorine in the merchant market or in the form of hydrochloric HCl and bleach.

16:51Following the down merger, it acquired a more diversified chlorine envelope with the addition of some vinyl exposure plus some epoxy resin exposure and some chlorinated organics exposure. As I said, depending on what you're selling, the distribution is different. If it's merchant chlorine, Olin is primarily shipping that via rail car into the interior of the country and then that's getting consumed by industries like TI02 and DINTDI, which are two of the precursors used to make various types of foam. And then the HCL and bleach are typically sold to municipalities who use it for water treatment.

17:31That's bleach. HCL is sold primarily to oil, natural gas and steel producers. And then on the vinyl intermediate side, Poland doesn't actually produce any PVC. It does produce some vinyl intermediates like EDC or VCM, which are the precursors that end up becoming PVC. For EDC, Poland is actually the world's largest merchant producer. Most of the rest of the world's EDC is forward and integrated into VCM and then ultimately PVC. And then, Poland does also produce some VCM to one large customer. That's Shintek. And then on the epoxy business, again, when the oil and reports that they report epoxy as a separate business, but it's really just another chlorine derivative.

18:16And so I would think of it as one of several options that oil and can direct chlorine too. And the epoxy side of things, they can choose to sell the molecule upstream in the form of epichlorohydrate or process it further downstream into epoxy systems and formulations. and then sell a more processed version of that to customers. Can you give the quick snapshot just in terms of percentage of whether you measure it by revenue or if they break it out by EBITDA even better when it comes to the Chloralculide business, the ammunition business, they split out the epoxy business. Just what the snapshot is for each of those businesses within Olin?

19:00The answer to your question is it kind of depends Because it's a cyclical commodity business, at the peak of the cycle, the cyclical commodity piece is going to account for a larger percentage of your EBITDA because you're at peak earnings. And at the trough of the cycle, it's going to account for a lot less versus the ammunition business, which is comparatively much more stable. 2021 and 2022 were both peaky years for the chloralkalye business. is and each of those years the Chloralculi business accounted for over 80 % of the EBITDA, but in a trough year, it's going to account for much less than that.

19:39Okay. And for context, how low would that possibly go from 80 % to 50 % or I know you're not going to be exact in terms of those forecasts, but I'm just wondering how cyclical this cyclical commodity actually is. Let's just do some quick mental math here. Winchester will probably end the year at around $250 ,000 to $300 million of EBITDA. And total EBITDA for the entire company is probably close to $1 .4 billion this year. So they'll still 70 to 75%. But in this case, it's just because the Chlorocloid business doors winchester in terms of EBITDA contribution. But going from close to 90 % to 70 % is a big swing for the commodity piece.

20:30Absolutely. And that can bring us back to one of your earlier points just in terms of how they involve themselves in the overall value chain and not being as integrated with the of INALS business. How does that shift the profile? I assume it just gives more pure commodity exposure, but is there anything else that goes into that thinking in terms of through the cycle normalized rates of return and how you as an investor would think about them being more or less integrated with some of the end markets? What's interesting, I'm sure we'll get into the change in operating philosophy later, but before 2020, I would say Olin's business was always more levered to the fortunes of the cost -except of the business.

21:23That was because it was not as forward -integrated into PVC like its peers. What you had was a situation where when housing and construction were strong, PVC demand would be strong and because PVC demand was strong there would be a pull on chlorine and so all of Olens peers who are more integrated into PVC on the chlorine side of the business they would produce as much material as they could and as we talked about earlier what's unique about the chloroclyceric process is that it's a co -production process and so when you are producing for chlorine, you also have to produce caustic soda. And what ended up happening in that type of environment is there would be excess caustic soda.

22:13And because Olin's fortunes were more levered to the caustics out of the business, they would benefit from some of that chlorine strength. But it was not more than offset, but it was offset to an extent that wasn't optimal for their setup, even in the year like 2018 where the industry was going through a peak, Olens EBITDA topped out at around 1 .3 billion. And I think this was the key insight that Scott Sutton, who took over as CEO, had in 2020 when he changed the operating philosophy. Yeah, there's some similarities again to tie back a little bit to the group process of associated gas being produced or even NGLs where it can depress the price of those commodities because they are just simply being produced along with the crude oil.

23:04And that can have a massive impact on some businesses that have that diversified exposure and aren't pure play crude oil producers. Let's get into Scott Sutton what he's done where he came from prior to Olin and some of the changes that he made for the business, he mentioned the chain in operating philosophy. What did he do to adjust for that impact that you were mentioning before? Only just back up one or two years to give some context before Scott joined. So as I said earlier, there was a cyclical peak in the industry in 2018. Poland earned about 1 .3 billion, which is good but not great. 2019 was a tough year for that was the year when the stock had our radar screened and we learning about Nolan.

23:512019 was a weak demand year for caustic just driven by general industrial economy weakness. As I said, Poland has always been historically more levered to the fortunes of caustic and so caustic being weak was not a good macro situation for them.

24:12The one thing like producers are forward integrated in the PVC is not just because we have cheap access to electricity, but we also have access to cheap ethylene. And the way you make PVC is by combining chlorine with ethylene. And ethylene, just to give your listeners another primer on another commodity chemical, is the basic building block molecule that is produced from various fossil fuel derivatives. is. The marginal producer in Europe and Asia is producing that ethylene from NAPTA, which comes off the refinery. And as a result, it's tied to the price of oil. And then US producers, because of the shell revolution, have primarily shifted from NAPTA to ethane, which is a natural gas liquid that is a byproduct of shell oil and gas drilling.

25:05And because of that, ethane is generally tied to the price of Henry Hill natural gas prices and on a barrel of oil equivalent basis US natural gas is a lot cheaper than the Brent oil that Europe and Asia producers are using as feedstock and So for that reason the ethylene that we produce in the US Gulf Coast is also a lot cheaper US PVC producers just have a huge cost advantage and so in 2019 even though cost it was weak, the PVC producers were still producing, still running very chloroaclasts, like crazy, to take advantage of the cheap effluent cost position of the US. This drove a huge oversupplying cost that resulted in a decline in oil and zebra stock from 1 .3 billion that they earned in 2018 to just 900 million in 2019.

25:57Then what happened was COVID hit in 2020. Because the global economy shut down, you're demand for Olin's products, especially on the cross -six side fell off a cliff. In 2020 was a really tough year for them. I think the Rebeta fell from the 900 million in 2019 to just over 600 million. Now, I think the other unexpected event in 2020 that happened in addition to COVID was a change in leadership at the company. Scott Sutton became CEO in 2020 and upon taking the reins, he instituted a major change in the operating philosophy at the company. Essentially, he flipped the old model on its head and he switched to a model in which Olin would manage to the weak side of the model, or as he called it.

26:49Essentially, it was a value over volume strategy. And he wasn't entirely new to the business. He'd been on the board for a number of years. So he had an idea of, I think, how this operating model could work. Many had also previously run the acetacetic acid business at Celenies in a similar fashion. I think what made Cloralkyli uniquely suitable to this operating model was the fact that the Cloralkyli industry, unlike the acetacetic acid industry, and for that matter, most other commodity chemical value chains produces, as we've said multiple times, two different molecules through one process operating at one operating rate.

27:35And if you are always managing to the weaker of the two molecules that are co -produced, and otherwise only producing as much product as there is demand for the weaker of the two, effectively your under -supplying the stronger side of the market can therefore push pricing in that market to enhance value. At the same time, instead of pushing excess product into the weaker market, which would depress margins even more, you're preserving value by not oversupplying the weaker market. It's a win -win. On paper, it makes a lot of sense from that 10 ,000 -foot view, but executing is pretty complicated.

28:17under the hood, what you're essentially having to do is every day determining Olin's participation rate based on a three -step decision tree. The first decision node is the simplest and that's is caustic cheaper or is chlorine cheaper a weaker and once you determine that then you set your production to the weaker side of the market. The second decision node on the chlorine side of things is which chlorine derivatives chain do I want to participate in? Is it a Do I want to produce more merchant? Do I want to produce more vinyls and remediates? Or do I want to produce more chlorinated organics? And then the final step is determining how far up and down each of those chlorine derivatives chains, do you want to manufacture?

29:04Do you want to let the epoxy out at the chlorohydrate? Or do I want to process it further into epoxy systems? So essentially just became a very simple volume over value low cost commodity strategy to a much more complex commercial model where you're moving with more agility to maximize the overall value of the Chloralki molecule. So basically an interesting optimization problem. Super interesting. The amount of variables that are going into that, just fascinating to me. And I want to unpack a few of those. From the start, the idea that you're going to push less volume into the cheaper market, therefore you should see some improvement on price.

29:55How confident have they been that that optimization is actually going to play out to their benefit? I think you can make the case as well that you would want to push onto the market. And if you're the low -cost producer, push out some of the higher -cost competitors, but in this approach, you might actually be letting them survive. In terms of the early results, how have they proven to be just in terms of implementing this strategy to success and not losing share or whatever it might be from competitors? We asked ourselves that same question when Scott took the reins, because I think the knee -jerk reaction is if it's so simple why hasn't it ever been done.

Read the full transcript

30:34I think the simple answer to that is before the Dow acquisition was always not a bit player but one of the smaller players in the US market but the Dow transaction actually really changed that and it became the underpound gorilla in the market and the US market is pretty consolidated even though the global industry, chloroclay industry is somewhat fragmented but within the US really have the four large players accounting for 85 to 90 % of market share. And for the US markets versus the international markets, do exports play a role? Is it something that when you factor in export cost and the transportation associated with that, it is a global market that operates globally?

31:17There is global trade. I would say the products that are traded where you see the most global trade are PVC because it's easy to ship resin or little pellets and maybe epoxy and caustic soda. But even with something like caustic, the US market is at any point in time exporting 3 million tons, but only importing a couple hundred thousand tons. So there's not that much liquidity. Certainly not to the extent that oil is globally traded. Then there are certain things like merchant chlorine, for example, that you just can't and the market. Those are all reasons why there are some parts of this industry where it is a global market and other parts where the local regional dynamics matter more.

32:03To answer that question, I think the model worked better in a more accelerated timeframe than I think anyone anticipated, including Scott and the management team at Owen. And if we just look at what happened in 2021, from a macro perspective, the macro backdrop in 2021 was a suboptimal one for Owen, historically speaking. I talked earlier about how, when housing demand is strong, that's not a good setup for Owen because there's a poll on PVC and then there's a poll on chlorine and that creates an oversupply of caustic, which they had historically been more levered to from a financial results perspective.

32:44Despite that in 2021, Olin generated 2 .5 billion of Ipidah, and that's the most Ipidah that they have regenerated, and I think you can attribute a lot of that success to the strategy pivot, basically instead of chasing the strong side of the molecule, which was chlorine at the time and oversupplying the caustic market, Bolin exercise restraint, limited production to the demand that it saw on the weak side of the market, which is oscastic, and that preserved value in the weaker market. And at the same time, made a strong chlorine market even stronger. Although they were not benefiting from the vinyl side of things, they have a very dominant position in merchant chlorine and they were able to exercise pricing power in that market.

33:43And in 2022, I think you saw another year where they generated close to 2 .5 billion of EBITDA again. Two years where they generated levels of EBITDA that were almost 2X the last cyclical peak in 2018. It's impressive for a business that is 2X the cyclical peak, but between then also was down 50%. And yes, COVID played a role in that too. But to see EBITDA drop to, did you mention 600 million? In 2020, yeah, a little over 600 million. Yeah, it's absolutely incredible. Is the expectation that this will make EBITDA less cyclical? So when you think about the next potential trough 2021 was a non -optimal period of time.

34:27But I'm just wondering the test in terms of the downside risk to this model, what does that look like? So we're going through it right now. The first half of 22 was a very strong year. I think you started to see the economy slowed down in the back half of the year and into this year. So in April of 2022, the new management team, Webby Scott, put out for the first time a new estimate of what they think trough economics would look like under this new operating model. You've recession case range that he put out was one and a half to two billion. So big numbers relative to prior troughs. And so as you can imagine, that 1 .5 to two billion dollar earnings corridor was met with a lot of skepticism.

35:13And that's natural because in any cyclical commodity business, I think investors tend to anchor to historical precedent. And what Olin was selling was essentially a, this time, his different story. So base rate of those playing out as advertised is fairly low. This year is not over, but it's looking like EBITDA will come in just below the one and a half to two billion, quarter at around 1 .4 billion. So something for both bulls and bears to point to to take a victory lap. I think from our perspective, whether it's 1 .4 or 1 .5 billion, does it matter so much is the fact that it is a much higher level of earnings than in prior troughs.

35:55And more importantly, the free cash flow is also much stronger, which gives you a lot of downside protection. So just to give some context, this year they should be able to do something like on that 1 .4 billion of EBITDA, close to 700 million of free cash flow versus in 2020, EBITDA was a little over 600 million and free cash flow was, I believe, a little over 100 million. If we just look at that in nominal terms, I think that's 500 millionish in terms of the cap expend in that scenario Where are those dollars going or is it some other use of cash in terms of taking the EBITDA conversion towards free cash flow?

36:32they have since 2020 I think maybe the end of 2021 or maybe it started in the beginning of 2022 deployed Most of that free cash flow or in 2021 they do a lot of the left thing And so the balance sheet is carrying a lot of leverage because it wasn't very free cash flow generative in 2020 nor in 2019 to pit out a lot of debt in 2021 in 2022 They really ramped up stock buybacks and share repurchase activity in a very meaningful way We were very supportive of that because if you looked at the free cash flow yields even on a normalized basis the stock Always traded above a 10 % free cash flow yield and even this year on trough free cash flow of it's trading at about a 10 % trough recast for you.

37:18And so we don't disagree with the management and the board's decision to allocate that capital, essentially you're investing in your own shares at a 10 % free cash for you. And it's probably hard in this environment to find a more attractive use for that capital. It's a 10 % trough recast for you, the much higher free cash for you don't normalize free cash for. Yeah, that makes sense. And I think you've referenced the EBITDAM metrics. What has the margin profile look like for the business? I'm assuming there's this expanding margin that's playing the role in terms of the EBITDAG growth, but what was that historically?

37:58And what does that look like now? And whether you look at it per segment or at the overall business level, whatever you think is easiest. When I forecast business like this, I don't really think about it on a normalized EBITDAM margin basis because the earnings power or at any point the cycle is dictated by supply and demand. And even if your costs are high, you should be able to pass those on if the supply demand dynamics is in your favor. But just to make it more apples to apples to other businesses, say at trough EBITDA margin on a consolidated basis is probably anywhere between 10 to 15 % and at peak probably between 25 % 30%, 21 and 22 were both in that 25 to 30 % area code, but 23 is going to be lower than that.

38:45I'm also curious just about the financial results relative to expectations and some businesses are notoriously hard to forecast. When they report results, you'll see 20 to 30 % in either direction. I think US refiners are very popular for that specifically. It's just incredibly difficult to forecast what a quarter is going to look like. How does that compare to Olen? Are you getting that same type of volatility in terms of the actual results? I may not be the best person to answer that because we obviously track the quarterly earnings calls, but our investment horizon is typically anywhere between three to five years and there are some stocks that we've held for much longer.

39:30I think the way that the lens that we see Olen is more on a normalized mid -cycle basis and the reason we get involved in investments like this is because we think the stock is cheap on a normalized mid -cycle basis. And so whether or not they miss or beat a quarter is not super important to us. And for that reason, I don't spend a lot of time refining my quarterly forecast. Yes, I think what does matter is that they have the balance sheet resiliency to make it through tough conditions, like the conditions that we're going through now. And so such that if they do have a particularly tough quarter, they don't have to do something dilutive from a shareholder value perspective.

40:21But outside of that, I don't have a really strong view of what this quarter and next quarter will look like. They're always felt like there was something silly about forecasting quarters for refineries when there was evidence that it didn't do much good. And even if they beat by a massive amount, it might not matter depending on what the guidance was. The other question I had is does this market have futures activity hedging? Is that something that's common? We got into the weeds in terms of changing daily operations to adjust a price. the other option that would be out there is to find some type of financial instrument that will allow you to hedge.

41:00So is there a futures market or is it almost entirely exposed to spot? On the revenue side of things, there is a spot market and then they also sell some product on contract. For business like all in general, I think our view would be that if you have an advantage cost curve position, you should probably have as much spot exposure as you can in order to capture the through the cycle economics. I think Olin historically probably had a higher mix of contracted sales to spot sales than it does currently and I think that's intentional. I think Scott's view is that you want to have the flexibility to have as much of your portfolio sold on a spot basis as possible in order to maneuver with agility depending on rapid changes in the marketplace.

41:55If too much of your volume is contracted then you'll be hamstrung won't have that flexibility to move with agility. They do do some hedging on the cost side so I think I believe they're for their co -gemplants where they operate e -neutral gas for that and I think they do some hedging one year out. The Winchester business, a small piece of the overall pie, but still worth mentioning and tapping on a little bit. How would you view that business within the overall Olin pie in terms of what value it provides to them? Is it something that they would ever potentially divest? How important of a role does it play?

42:34And how much investor attention does it get from someone like you? When we first looked at the company in 2019, it felt like to us Winchester was a potential candidate for divestment because it was non -core. I think since then there's been a shift from at the board and management level. It's not an area where they're investing heavily, and so it's non -core from that perspective, but it is very cash -generative asset where Olin has a pretty strong position in the market. And so I think they want to hold onto it for that reason, mainly because there aren't that many good, divested options for this business.

43:18If you just look at where the public comps trade, it's not a particularly attractive alternative option from a shareholder perspective. I think Winchester often comes up in investor conversations because there are lots of people who from an ESG perspective can't own Olin because of the ammunition exposure. I think the question that you have to ask yourself is would the counterparty to whom Olin and divest the business be a better steward of Winchester or of any ammunition business, or would the world be better off with Olin owning Winchester and overseeing that ammunition business? I don't know that I have the answer.

44:07So that question, but I think it's a fair question to ask. But that's the context in which you often hear about Winchester. Yeah. I can certainly understand if the investor options are divesting this business at an extremely unattractive yield to the seller, 20 % free cash flow, and you could actually just take that cash flow and then Fested right back into your own business. That's the accretive option. And I think between the operations and perhaps the overall Company management, they they show to have a knack for being thoughtful about where pricing is in the markets, whether those be The chlorine operational markets or something like their own assets and their own businesses.

44:45I want to transition a little bit I think we've talked a lot about the change in the operational side of the business, the opportunity that exists within this business. I think we've hit on some of the risks, but maybe we can dive into those a little bit. One of them is a name that we've been mentioning quite frequently in terms of having a big impact on the business and that departure. Can we jump on that specifically, Scott Sutton announcing a departure? What that means for business where he's going and how you see it. Yeah, about a month ago, Olin announced that Scott would be leaving the company before the end of the first half of 2024.

45:25Both Scott and the board have underscored that this was a mutual agreement that did not result from any friction between the two sides in terms of the go -forward strategy and the board doesn't have any intention of changing the strategy or the operating model that Scott put into place when he became CEO. I think from our perspective, we have no doubt that there has been a real cultural shift within the company three years into Scott's tenure, but it still felt like Scott was a very important piece of the puzzle holding everything together at this juncture in the journey. So the announcement of his departure was definitely a surprise and for sure, I think, a loss for the company.

46:05I think from a sentiment perspective, it's to once again renew doubts and questions about Olin's ability to execute under the new operating model and deliver a higher level of earnings through the cycle. The stock was down 10 % the day that this was announced and I think that reflects that concern in the market. I think some reasons to be optimistic exist and I think they do have a senior leadership team in place that is fully on board with the new model. and they want to prove the ability of the new model to deliver a strong cash flow through peak and trough operating environments. And it does feel like this culture and this way of thinking about running the business has permeated the broader team.

46:53That makes you feel the businesses in capable hands, even post -Scott's departure. In that context, I think the most important thing at this point is to identify a successor who can step up and fail those biches and continue what Scott started. He's staying on to help the board identify his successors. So those are some mitigating factors to consider. Did you mention where he is going? He doesn't have another job lined up. Yeah, certainly interesting, especially looking for that successor, and it's always hard to think that there can be one person that really has the secret sauce and then give an industry.

47:32I have been proven wrong on that before and seeing where certain operators are that much better? To that point, Matt, what I would mention is that when Scott took over and announced this new strategy, we spoke to a couple of ex -Olan employees. And what they told us is that they were 100 % on board with the new strategy, but they said, Scott didn't come up with this idea on zone. There were individuals within the organization who wanted to run the model this way. And I think at the time, Orwin maybe just wasn't ready. It took an external person with the commercial courage, I think, for lack of a better word to go in there and institute that change.

48:14The Scott is certainly a very capable person, but I don't think that he's the only person who can effectively execute this new operating model. Yeah, it's a great example of where the voting machine versus weighing machine will come into play. having the stock down 10 % on announcement. Certainly reflects well, and I'm sure makes them feel better, you know, short term, but over the long term, you could see how business runs. What else would you point to just in terms of risks that you keep in mind for the business? I think the CEO departure is probably the biggest near term concern. What we worry about over the medium to longer term is just inevitable supply response.

48:54Although the current supply demand outlook is fairly benign for the chloralkolyte industry over the next four to five years. You know, that could certainly change if market participants recognize that the economics of the industry have structurally improved. And likewise, if Olin pushes to aggressively, from a pricing perspective in particular products, there is a potential risk that some customers start to seriously consider back integrating into chlorine on their own. They don't have to build a world -scale chloralkylife facility to do that. They could build something smaller and that wouldn't take as much time to build.

49:37You touched on it before, but when it comes to ESG, whether it be the Winchester business or just having some tie to chemicals, those can go in a variety of different directions, how does the business score or rank and is it a big overhang on the valuation of the business? From an ESG perspective, I think the biggest longer -term issue is carbon abatement because it's a energy intensive business. It has meaningful scope one and two emissions. And if the world wants to reach 2050 net zero targets, its industries like Chloralkyly are going to have to figure out a way to consume less fossil fuels, both at its feedstocks and as a source of energy and power.

50:28I think the path to net zero is still somewhat unclear for a lot of these industries, but what I would point out about the Chloralkyly industry is that it's starting with a bit of a head start versus its peers as we discussed earlier, PVC is a big end market for chlorocli, right, on the chlorine side and I believe it's the third most commonly used plastic polymer behind polyethylene and polypropylene and if you compare PVC to other polymers like polyethylene and polypropylene what's unique about PVC is that it's only 40 % fossil fuel. The other 60 % is salt, and that's because you start with the electrolysis of salt and water as feed socks as opposed to fossil fuel derivatives like ethane and naphtha, which are 100 % fossil fuel.

51:22You can make a case that where there's fungibility, right, switching to PVC, you're already starting with a lower carbon footprint. And I think the other thing that I would point out is that if carbon capture and storage gains momentum, the geology of the U .S. Gulf Coast with its depleted oil and gas reservoirs underground and the various salt caverns and the expertise. I mean, that already exists in that region around enhanced oil recovery. That sets up the region well and I think it could be a real competitive advantage for the region's petrochemical producers. On valuation, I think you've referenced looking at this business at free cash flow yield, whether it's normalized trough, but just framing it with that methodology.

52:11Is there anything else you use from a multiple perspective just thinking about how different investors would think about this business and what you would use and think about as the norm here? I like to think of this business on trough and mid -cycle free cash flow yield. I think in general, we're somewhat unique in that we think about all of our investments on a price to normalize earnings basis, and we're diagnostic as to how that cash flow earnings is generated. And so we buy stocks that are in the cheapest quintile on a price to normalize earnings basis. We're pretty disciplined about selling them when they reach the median of the universe.

52:54Olin is obviously still very, very cheap from our perspective on a normalized earnings basis and normalized recache for a basis, it is somewhat unique in the sense that I think there are very few investments where the stock has tripled and where we still retain a pretty sizable position in the stock, but I think that kind of speaks to the excellent job that the new management team has done in terms of delivering a structurally higher level of learning's power. I know you have a rich history at your firm. I would love to see a list of companies that have tripled that you've held on to would be an interesting case study of different investments, but I won't hold to do that.

53:38We close out the discussions trying to look for lessons that you learn from this business that you might be able to apply elsewhere as an investor. Is there anything that stands out here in terms of this business and the research that you've done? Let me caveat what I'm about to say by first acknowledging that the final chapter in the oil and story has yet to be written. But assuming this change in operating philosophy ultimately does prove to be successful and the earnings are structurally higher through the cycle, then I think there are a couple of important lessons from an operating perspective.

54:16The old and story really underscores the importance of questioning conventional wisdom in any business to avoid anchoring bias, even in a business as boring and mature as Chloralcoli. And I think in Olen's case, even though the scale and the capability of the company really was transformed following the down merger, and even though there were individuals inside the organization agitating for change in operating philosophy, it took an outsider, Scott, to shake things up and try something different. From an investment perspective, there are two important lessons. One is that I think the Olen story really underscores the importance of continuously revisiting your investment thesis and having the humility to recognize when things have changed because the world we live in is very dynamic and there were a lot of sleepless nights when COVID hit and we had to ask ourselves if Olin really had as much downside protection as we thought.

55:22Similarly, when the strategy shift was playing out, our initial reaction was let's blow out of this thing before the cycle turns again. As I said earlier, even though we've trimmed the position along the way, we still own a pretty sizable position because we've re -underwritten the thesis and still think the stock price under values, the mid -cycle learnings power of the business. The second lesson, and just for some context, I trained at Columbia Business School and the Valley Investment Program under a lot of great investors. At Columbia, there was a real focus on identifying companies with sustainable competitive modes that can compound value over time.

56:02I think a lot of value investors in that quality value camp invests that way. I have a lot of respect for that school of investing, but I think it does tend to overlook certain segments of the market, including cyclical commodity businesses. And I think what all in demonstrates is that there can be, and there are great investment opportunities, even in cyclical commodity industries, so long as you're starting with a strong cost position, and a resilient balance sheet, and an understanding of where you are in the capital cycle. I think that point typically it's hard to associate something that's tied into the commodity business with value, but when you pair that with what you mentioned before in terms of a new way of operating a very old business can be really interesting opportunity.

56:52So you know, it has been a pleasure. I have learned a ton throughout this conversation on a bunch of categories. I knew very little about. So thank you for joining us on business breakdowns and giving that excellent breakdown on all of it. Thanks for having me. To find more episodes of breakdowns ranging from Costco to Visa to Moderna or to sign up for our weekly summary, check out JoinColossus .com. That's J -O -I -N -C -O -L -O -S -S -U -S .com.

From the publisher

This is Matt Reustle and today we are breaking down Olin Corporation. Olin is a key player in industrial chemicals but many of those chemicals are used in products that we encounter on a day-to-day basis. To break down Olin, I'm joined by Yinan Zhao from Pzena Investment Management. Together we cover the chlor-alkali market, what it means to be the lowest-cost producer of a given commodity, and how Olin has shifted its business model and its operational model to help sustain earnings through cycles. Please enjoy this breakdown of Olin Corp.

Interested in hiring from the Colossus Community? Click here.
Subscribe to Colossus's New Show: Art of Investing

For the full show notes, transcript, and links to the best content to learn more, check out the episode page here.

-----

This episode is brought to you by Tegus. Tegus is the modern research platform for leading investors, and provider of Canalyst. Tired of calculating fully-diluted shares outstanding? Access every publicly-reported datapoint and industry-specific KPI through their database of over 4,000 driveable global models handbuilt by a team of sector-focused analysts, 35+ industry comp sheets, and Excel add-ins that let you use their industry-leading data in your own spreadsheets. Tegus’ models automatically update each quarter, including hard to calculate KPIs like stock-based compensation and organic growth rates, empowering investors to bypass the friction of sourcing, building and updating models. Make efficiency your competitive advantage and take back your time today. As a listener, you can trial Canalyst by Tegus for free by visiting tegus.co/patrick.

-----

Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.

Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.

Follow us on Twitter: @JoinColossus | @patrick_oshag | @jspujji | @zbfuss | @ReustleMatt | @domcooke

Show Notes
(00:01:33) - (First question) - An elevator pitch for Olin
(00:02:56) - Investors looking at DuPont also look at Olin from a subsector perspective 
(00:03:55) - A brief history of Olin’s business
(00:07:40) - The process of creating Chloralkali and its uses
(00:11:25) - The similarities and differences when comparing the crude oil refining process and the creation of Chloralkali
(00:12:21) - The use of Olin’s chlorine in residential public pools 
(00:12:48) - The breakdown of manufacturing operations of Olin, control versus outsourcing
(00:18:14) - A snapshot of the revenue percentages of Olin’s businesses
(00:19:13) - The percentage range of Olin’s cyclical commodities 
(00:20:06) - The end markets that Olin integrates itself in
(00:22:47) - A background on CEO Scott Sutton and the shift in operating philosophy
(00:29:09) - Olin’s confidence in its new optimization strategies
(00:33:49) - The downside risk to Olin’s new business model
(00:35:53) - A breakdown of Olin’s CapEx spending 
(00:37:17) - The margin profile and EBITDA growth, historically and how it looks now
(00:38:20) - The difficulties in forecasting and similarities with oil refinery volatility
(00:40:02) - Market futures activity and hedging
(00:41:49) - The Winchester business and its position within the overall Olin pie
(00:43:49) - The announcement to the departure of Scott Sutton and the risks posed
(00:48:11) - Other potential risks to Olin’s business moving forward
(00:49:11) - A look at Olin’s ESG ranking 
(00:51:35) - Valuing the business and what investors might think about Olin
(00:53:12) - Lessons learned from researching Olin

More from Business Breakdowns

All 153 episodes
Olin: Chemistry and Cash Flows - [Business Breakdowns, EP.132]Business Breakdowns · 58 min
Listen in VO